Bio Green Med Solution, Inc. (NASDAQ:BGMS) — Stock Price
Bio Green Med Solution, Inc. (NASDAQ:BGMS) is currently trading at $0.90 USD, down 5.34% today. Over the past 52 weeks, shares have ranged between $0.60 and $5.95. This page tracks Bio Green Med Solution, Inc.'s live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Bio Green Med Solution, Inc. stock valuation.
Bio Green Med Solution, Inc. (BGMS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bio Green Med Solution, Inc.'s daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bio Green Med Solution, Inc. Income Statement — Revenue, Profit & Earnings by Year
Bio Green Med Solution, Inc.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $747.00K | $43.00K | $420.00K | $0.00 | $0.00 |
| Cost of Revenue | $609.00K | $0.00 | — | $32.00K | $43.00K |
| Gross Profit | $138.00K | $43.00K | $420.00K | $-32.00K | $-43.00K |
| Research & Development | $848.00K | $6.66 Million | $19.16 Million | $20.27 Million | $14.93 Million |
| SG&A | $7.72 Million | $5.39 Million | $6.72 Million | $7.38 Million | $7.46 Million |
| Total Operating Expenses | $8.56 Million | $12.05 Million | $25.87 Million | $27.66 Million | $22.39 Million |
| Operating Income | $-8.43 Million | $-12.00 Million | $-25.45 Million | $-27.66 Million | $-22.39 Million |
| EBITDA | $-8.42 Million | $-12.00 Million | $-25.42 Million | $-27.62 Million | $-22.35 Million |
| EBIT | $-8.43 Million | $-12.00 Million | $-25.45 Million | $-27.66 Million | $-22.39 Million |
| Interest Expense | — | — | — | — | — |
| Income Before Tax | $-2.99 Million | $-11.99 Million | $-25.55 Million | $-25.91 Million | $-22.18 Million |
| Income Tax Expense | $7.00K | $-782.00K | $-3.00 Million | $-4.72 Million | $-3.73 Million |
| Net Income | $-3.00 Million | $-11.21 Million | $-22.55 Million | $-21.20 Million | $-18.46 Million |
Bio Green Med Solution, Inc. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bio Green Med Solution, Inc.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $8.19 Million | $4.09 Million | $8.80 Million | $28.05 Million | $43.14 Million |
| Total Current Assets | $6.26 Million | $3.67 Million | $7.44 Million | $24.41 Million | $40.94 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $1.26 Million | $237.00K | $3.73 Million | $5.64 Million | $4.30 Million |
| Inventory | $1.38 Million | $0.00 | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | $1.57 Million | $0.00 | — | — | — |
| Total Liabilities | $1.34 Million | $6.27 Million | $8.20 Million | $7.62 Million | $5.44 Million |
| Total Current Liabilities | $1.33 Million | $6.27 Million | $8.16 Million | $7.51 Million | $5.41 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-3.50 Million | $-3.14 Million | $-3.34 Million | $-18.24 Million | $-36.53 Million |
| Total Stockholder Equity | $6.84 Million | $-2.17 Million | $607.00K | $20.43 Million | $37.69 Million |
| Retained Earnings | $-454.41 Million | $-439.49 Million | $-428.28 Million | $-405.73 Million | $-384.53 Million |
Bio Green Med Solution, Inc. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bio Green Med Solution, Inc. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-4.77 Million | $-7.99 Million | $-16.11 Million | $-20.83 Million | $-18.54 Million |
| Capital Expenditures | $0.00 | $0.00 | $6.00K | $7.00K | $27.00K |
| Free Cash Flow | $-4.77 Million | $-7.99 Million | $-16.12 Million | $-20.83 Million | $-18.57 Million |
| Investing Cash Flow | — | — | $-6.00K | $-7.00K | $-27.00K |
| Financing Cash Flow | $5.26 Million | $7.82 Million | $848.00K | $3.00 Million | $21.74 Million |
| Dividends Paid | $61.00K | $0.00 | $201.00K | $201.00K | $201.00K |
| Stock-Based Compensation | $2.33 Million | $592.00K | $1.47 Million | $1.51 Million | $1.16 Million |
| Depreciation | $5.00K | $6.00K | $31.00K | $32.00K | $43.00K |
| Change in Cash | $368.00K | $-241.00K | $-14.97 Million | $-18.21 Million | $3.15 Million |
Bio Green Med Solution, Inc. Earnings History — EPS Actual vs. Analyst Estimates
Track Bio Green Med Solution, Inc.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | -2.21 | — | — |
| Nov 13, 2025 | -1.31 | — | — |
| Aug 14, 2025 | -1.53 | — | — |
| Apr 02, 2025 | -0.33 | -6.08 | +94.57% |
| Nov 13, 2024 | -43.20 | -129.60 | +66.67% |
| Aug 15, 2024 | -172.80 | -344.40 | +49.83% |
| May 15, 2024 | -544.80 | -1183.20 | +53.96% |
| Mar 27, 2024 | -1495.31 | -0.41 | -361697.41% |